Bioharvest Financial Statements From 2010 to 2024
| CNVCF Stock | USD 6.15 0.03 0.49% |
Check Bioharvest Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioharvest Sciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Bioharvest financial statements analysis is a perfect complement when working with Bioharvest Sciences Valuation or Volatility modules.
Bioharvest |
Bioharvest Sciences OTC Stock Operating Margin Analysis
Bioharvest Sciences' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Bioharvest Sciences Operating Margin | (2.45) % |
Most of Bioharvest Sciences' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioharvest Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Bioharvest Sciences has an Operating Margin of -2.4469%. This is 93.02% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 55.59% lower than that of the firm.
Bioharvest Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bioharvest Sciences's current stock value. Our valuation model uses many indicators to compare Bioharvest Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioharvest Sciences competition to find correlations between indicators driving Bioharvest Sciences's intrinsic value. More Info.Bioharvest Sciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioharvest Sciences' earnings, one of the primary drivers of an investment's value.About Bioharvest Sciences Financial Statements
Bioharvest Sciences stakeholders use historical fundamental indicators, such as Bioharvest Sciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Bioharvest Sciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bioharvest Sciences' assets and liabilities are reflected in the revenues and expenses on Bioharvest Sciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bioharvest Sciences. Please read more on our technical analysis and fundamental analysis pages.
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product and medical cannabis. Canna-V-Cell Sciences is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Bioharvest OTC Stock
Bioharvest Sciences financial ratios help investors to determine whether Bioharvest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioharvest with respect to the benefits of owning Bioharvest Sciences security.